Aberrant changes in growth factor processes can lead to abnormal cell growth and cancer and tumor formation. Malignancy can be triggered via the unregulated expression of growth factors and there corollary signaling pathways.
Different methods of targeting growth factor related cancer formation may be indicated including antagonists, monoclonal antibodies , receptor inhibitors, protein tyrosine kinase inhibition and cell transcription pathway interventions.
Primary Description: | Mouse Anti-Insulin-Like Growth Factor [7973] |
Product Reference Code: | IQ391 |
Species Reactivity: | Human, Mouse, Rat |
Applications: | RIA, ELISA, IHC(Fr), IHC(P) |
Primary Description: | Mouse Anti-Parathyroid Hormone Receptor 1 [3D1.1] |
Product Reference Code: | IQ393 |
Species Reactivity: | Human |
Applications: | ELISA, Flow Cytometry, WB, IHC(P) |
Primary Description: | Mouse Anti-Human TGF beta1 [TB21] |
Product Reference Code: | IQ159 |
Species Reactivity: | Human |
Applications: | ELISA, IHC(Fr), IHC(P), WB |